If a company builds assets at 27% a year, faster than its revenue growth rate of 16.4% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Beijing Strong Biotechnologies's average Total Assets Growth Rate was -2.20% per year.
During the past 3 years, the average Total Assets Growth Rate was 9.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 27.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 33.80% per year.
During the past 13 years, Beijing Strong Biotechnologies's highest 3-Year average Total Assets Growth Rate was 45.60%. The lowest was 9.60%. And the median was 32.65%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Strong Biotechnologies Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Strong Biotechnologies (SZSE:300406) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Sep. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Beijing Strong Biotechnologies's Asset Turnover for the quarter that ended in Sep. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Beijing Strong Biotechnologies Total Assets Related Terms
Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Beijing Strong Biotechnologies Business Description
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300406 has been successfully added to your 